国际肿瘤学杂志››2015,Vol. 42››Issue (4): 295-297.doi:10.3760/cma.j.issn.1673-422X.2015.04.015

• 综述 •上一篇下一篇

原癌基因Bmi-1与非小细胞肺癌

  1. 530021 南宁,广西壮族自治区人民医院化疗科
  • 出版日期:2015-04-08发布日期:2015-04-22
  • 通讯作者:冯国生,Email: Fengguosheng88988@163.com

Proto-oncogene Bmi-1 and non-small cell lung cancer

  1. Department of Chemotherapy, the People′ s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
  • Online:2015-04-08Published:2015-04-22
  • Contact:Feng Guosheng, Email: Fengguosheng88988@163.com

摘要:B细胞特异的莫洛尼白血病毒插入位点1(Bmi1)基因是多梳基因家族的核心成员之一,被认为是一种原癌基因,在细胞的自我更新、增殖及凋亡方面发挥重要作用。研究证实,Bmi1的高表达与非小细胞肺癌的发生、发展、侵袭及预后密切相关。Bmi1基因有望成为一种新的肿瘤分子标志物,为非小细胞肺癌的诊断、靶向治疗提供新的方向。

关键词:原癌基因,癌,非小细胞肺,Bmi-1

Abstract:B-cell specific moloney leukemia virus insertion site 1 (Bmi-1)gene is a core member of the polycomb group genes, considered to be a proto-oncogene; Bmi-1 plays an important role in cell selfrenewal, proliferation and apoptosis. Several studies have shown that Bmi-1 is highly expressed in non-small cell lung cancer; furthermore, the expression level of Bmi-1 is closely related to the occurrence, development, incursion and prognosis of nonsmall cell lung cancer. Bmi-1 is expected to become a novel tumor molecular marker, and provides a new direction for the treatment of non-small cell lung cancer.

Key words:Proto-oncogene,Carcinoma, non-small-cell lung,Bmi-1